Total RNA was isolated from CFs on a collagen vitrigel membrane or from HCE cells in a 30-mm dish with the use of a kit (RNeasy; Qiagen, Valencia, CA), and portions (0.5 μg) of the RNA were subjected to reverse transcription (RT) and polymerase chain reaction (PCR) analysis with a kit based on the Platinum Taq system (One-Step; Invitrogen, Carlsbad, CA). The PCR protocol was designed to maintain amplification in the exponential phase. The sequences of the PCR primers (sense and antisense, respectively) were 5′-AGAATTTTGACTCTCCAGAAAGC-3′ and 5′-AGTTATCCCTTGCCTATCCAG-3′ for MMP-1, 5′-GTTCATTTGGCGGACTGTG-3′ and 5′-TCACGCTCTTCAGACTTTGG-3′ for MMP-2, 5′-GCCTCATGCTCTGTTCTTGG-3′ and 5′-GGTTCTTGTGACGCCTTCTG-3′ for IL-1RA, and 5′-ACCACAGTCCACGCCATCAC-3′ and 5′-TCCACCACCCTGTTGCTGTA-3′ for glyceraldehyde-3-phosphate dehydrogenase (G3PDH, internal control). The RT and PCR incubations were performed with a thermal cycler system (GeneAmp 2400-R; Perkin-Elmer, Foster City, CA). RT was performed at 50°C for 30 minutes, and PCR was performed for 25 cycles, with each cycle comprising incubations at 94°C for 2 minutes, 58°C for 30 seconds, and 72°C for 1 minute. The reaction mixture was then cooled to 4°C. The products of amplification were fractionated by electrophoresis on a 1.5% agarose gel and were stained with ethidium bromide. For RT and real-time PCR analysis, total RNA was subjected to RT with a kit (Promega), and the resultant cDNA was subjected to real-time PCR analysis by rapid cycling in glass capillaries with the use of a thermocycler (Light-Cycler; Roche Molecular Biochemicals, Indianapolis, IN).